Royalty Payments and Reports. BMS shall calculate all amounts payable to MTEM pursuant to [Section 7.6] at the end of each ​, which amounts shall be converted to Dollars in accordance with [Section 7.8]. BMS shall pay to MTEM the royalty amounts due with respect to a given ​ within ​ following the end of the ​ in which the Net Sales on which such royalty amounts are due are deemed to have occurred. With each payment of royalties due to MTEM, BMS shall deliver a report to MTEM specifying: # the amount of Net Sales of each Licensed Product in each country in the Territory during the applicable ​; # to the extent such Net Sales include sales not denoted in Dollars, a summary of the then-current exchange rate methodology used by BMS; # the applicable royalty rates under this Agreement (including any reduction(s) to such royalty rates under [Section 7.6]); # a calculation of the amount of royalty payment due on such Net Sales for such ​; and # the date of the First Commercial Sale of each Licensed Product in each country in the Territory that has occurred during the corresponding ​. For clarity, no royalties shall be due or payable to MTEM on any future sales of Licensed Product in a country (that occur after expiration of the applicable Royalty Term) held in inventory as of the date of expiration of the Royalty Term in that country.

Royalty Payments and Reports. ​. Within ​ days following the end of each ​ following the First Commercial Sale of a Licensed Product, Lian shall furnish to Lyra a written report for the ​ showing ​. Such written report shall include ​. Lian shall pay Lyra the royalty due for such Calendar Quarter calculated in accordance with this Agreement within ​ days of delivery of the written report to Lyra.

Royalty Payments and Reports. The royalty set forth in this Section 6.1 shall be payable within ​ following the end of each Calendar Quarter. No later than the end of such ​ period, Tracon shall provide to Eucure a report summarizing the amount of Net Sales of Collaborative Product sold in the Field, on a country-by-country basis, in the Collaborative Territory and the amount of royalty owed with respect to such Net Sales for such Calendar Quarter.

Royalty Payments and Reports. PARTNER # shall provide REGENX, no later than ​ after the end of each ​, with a preliminary, good faith estimate of all amounts payable to REGENX pursuant to Section 8.3.1 at the end of such ​ and # shall calculate all amounts payable to REGENX pursuant to Section 8.3.1 at the end of each ​, which amounts shall be converted to Dollars, in accordance with Section 8.6. PARTNER shall provide REGENX, no later than ​ after the end of each ​, with a statement specifying, on a country-by-country basis, ​, in each case attributable to a Licensed Product for use in each Indication of the Licensed Field in each country in the Royalty Territory during the applicable ​ (including such amounts expressed in local currency and as converted to Dollars) and a calculation of the amount of royalty payment due on such Net Sales for such ​. PARTNER shall pay to REGENX the royalty amounts due with respect to a given ​ within ​ after the end of such ​. Without limitation of the generality of the foregoing, PARTNER shall require its Affiliates and Sublicensees to account for their Net Sales and to provide such reports with respect thereto, as if such sales were made by PARTNER.

Royalty Reports and Payments. All payments under Section 4.1 shall be due and payable within ​ during which the corresponding Net Sales are made. Together with any such payment, Licensee shall deliver a report specifying in the aggregate and on Product-by-Product basis: # total gross invoiced amount from sales of Products by Licensee; # amounts deducted by category (as identified in Section 1.7) from gross invoiced amounts to calculate Net Sales; # Net Sales and # royalties payable. If no royalties are due, Licensee shall so report. Such reports shall be deemed to be the Confidential Information of Licensee.

Royalty Payments and Reports. Licensee shall calculate all amounts payable to [[AstraZeneca:Organization]] pursuant to Section 4.4.1 at the end of each Calendar Quarter, which amounts shall be converted to Dollars, in accordance with [Section 4.6]. Licensee shall provide a written statement (a “Payment Statement”) that includes such calculation to [[AstraZeneca:Organization]] in writing within ​ of the end of the Calendar Quarter, which Payment Statement shall include, on a Licensed Product-by-Licensed Product basis, the amount of Invoiced Sales, Net Sales and deductions taken to arrive at Net Sales attributable to each Licensed Product in each country in the Territory during the applicable Calendar Quarter (including such amounts expressed in local currency and as converted to Dollars) and a calculation of the amount of Royalty payment due on such Net Sales for such Calendar Quarter. Following receipt of such Payment Statement, [[AstraZeneca:Organization]] shall submit an invoice promptly, but no more than ​ following receipt of such Payment Statement, to Licensee for the full amount of the corresponding Royalty payment. Licensee shall pay to [[AstraZeneca:Organization]] the Royalty amounts due with respect to a given Calendar Quarter within ​ after the receipt of the invoice. Without limiting the generality of the foregoing, Licensee shall require its Affiliates and Sublicensees to account for their Net Sales and provide reports with respect thereto, as if such sales were made by Licensee.

Royalty Payments and Reports. Ono shall report to [[Forty Seven:Organization]] in writing all amounts payable to [[Forty Seven:Organization]] pursuant to [Section 9.3] within ​ following the end of each Calendar Quarter. Such report shall include the converted US Dollar amounts, which conversion shall be made at the Exchange Rate for each calendar month in the Calendar Quarter. Such written report shall include, on a consolidated basis in reasonably specific detail and on a country-by-country basis, # the Net Sales of Products sold by Ono, its Affiliates and its Sublicensees in the Ono Territory during the corresponding Calendar Quarter, including a description of the credits and offsets deducted on a Product-by-Product and country-by-country basis to calculate Net Sales; # the royalties payable in US Dollars, if any, which shall have accrued hereunder based upon such Net Sales of Products; # the withholding taxes, if any, required by law to be deducted in respect of such royalties; # the dates of the First Commercial Sale of each Product in each country in the Ono Territory, if it has occurred during the corresponding Calendar Quarter; and # an itemized calculation of the exchange rate used by Ono in determining the royalty amount expressed in [[Address B:Address]]ese Yen, in accordance with Ono’s consolidated accounting procedure, as consistently Execution Version

Royalty Reports and Payments. Within [* * *] following the end of each calendar quarter, commencing with the calendar quarter in which the First Commercial Sale of any Product is made anywhere in the Territory, Catalyst shall provide ISU with a written report containing the following information for the applicable calendar quarter, on a country-by-country and Product-by-Product basis: # the amount of gross sales of Product in the Territory, # a calculation of the royalty payment due on such Net Sales, and # the exchange rate for such country. Concurrent with the delivery of the applicable quarterly report, Catalyst shall pay in Dollars all amounts due to ISU pursuant to [Section 7.1] with respect to Net Sales by Catalyst or its Affiliates for such calendar quarter. Catalyst will be required to provide the above report on a quarterly basis, regardless of the amount and/or level of sales in a particular quarter.

Royalty Reports and Payments. After the first sale of a product on which royalties are payable by a Party hereunder, such Party shall make quarterly written reports to the other Party within sixty (60) days after the end of each calendar quarter, stating in each such report, separately the number, description, and aggregate Net Sales, by territory, of each such Product, Other Biogen Idec Product, Reverted Product, Sunesis Product, [[Unknown Identifier]] Product or [[Unknown Identifier]] Reverted Product sold during the calendar quarter upon which a royalty is payable under [Section 7.5] or [Section 7.6] above, as applicable. Concurrently with the making of such reports, such Party shall pay to the other Party royalties due at the rates specified in [Section 7.5] or [Section 7.6] above, as applicable.

Royalty Payments and Reports. [[Organization A:Organization]] shall calculate all amounts payable to Licensor pursuant to Section 7.6 at the end of each Calendar Quarter, which amounts shall be converted to Dollars, in accordance with [Section 7.8]. [[Organization A:Organization]] shall pay to Licensor the royalty amounts due with respect to a given Calendar Quarter within ​ after the end of such Calendar Quarter. Each payment of royalties due to Licensor shall be accompanied by a statement of the amount of Net Sales of each Licensed Product in each country or other jurisdiction in the Territory during the applicable Calendar Quarter (including such amounts expressed in local currency and as converted to Dollars) and a calculation of the amount of royalty payment due on such Net Sales for such Calendar Quarter.